Hyo Song Kim

11PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 06, 2026
Phase IB/II Trial with Correlative Analyses of Doxorubicin plus Durvalumab Combination in Patients with Advanced Soft Tissue Sarcoma.

Kum-Hee Yun, Nam Suk Sim, Su-Jin Shin

|Feb 16, 2024
Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II Study.

Jin-Hee Ahn, Jeeyun Lee, Changhee Park

|Jan 23, 2024
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial.

Hee Jin Cho, Kum-Hee Yun, Su-Jin Shin

|Nov 06, 2023
Impact of Coronavirus Disease 2019 on Gastric Cancer Diagnosis and Stage: A Single-Institute Study in South Korea.

Moonki Hong, Mingee Choi, JiHyun Lee

|Oct 26, 2023
Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study.

Choong-Kun Lee, Hyo Song Kim, Minkyu Jung

Pageof 2